Gene: MSANTD7
Official Full Name: Myb/SANT DNA binding domain containing 7provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16009 | MSANTD7 Knockout cell line (HeLa) | Human | MSANTD7 | 1:3~1:6 | Negative | Online Inquiry |
KO16010 | MSANTD7 Knockout cell line (HCT 116) | Human | MSANTD7 | 1:2~1:4 | Negative | Online Inquiry |
KO16011 | MSANTD7 Knockout cell line (HEK293) | Human | MSANTD7 | 1:3~1:6 | Negative | Online Inquiry |
KO16012 | MSANTD7 Knockout cell line (A549) | Human | MSANTD7 | 1:3~1:4 | Negative | Online Inquiry |
MSANTD7 Gene Knockout Cell Lines represent a significant advancement in genetic research, providing scientists with a powerful tool for investigating the functional role of the MSANTD7 gene in various biological processes. These engineered cell lines are developed through precise CRISPR-Cas9 technology to selectively disable the MSANTD7 gene, enabling researchers to study the resulting phenotypic changes, cellular pathways, and interactions without the confounding effects of gene expression.
The key function of MSANTD7 Gene Knockout Cell Lines lies in their ability to facilitate detailed investigation into the gene's contribution to cellular homeostasis, signaling, and disease mechanisms. By utilizing these knockout models, researchers can effectively dissect the molecular pathways involved in conditions such as cancer, metabolic disorders, or neurodegenerative diseases. The elimination of the MSANTD7 gene allows for a clearer understanding of protein interactions and cellular responses to different stimuli, driving informed hypotheses for follow-up studies.
In research and clinical settings, the MSANTD7 Gene Knockout Cell Lines are invaluable for drug testing and biomarker discovery. These cell lines provide a robust platform for high-throughput screening, allowing for the identification of potential therapeutic targets and the evaluation of drug efficacy in a controlled genetic background. The culmination of these efforts not only contributes to the advancement of basic scientific knowledge but also paves the way for innovative treatment strategies.
What sets MSANTD7 Gene Knockout Cell Lines apart from conventional alternatives is their precision and reliability. The CRISPR-based editing ensures high efficiency and specificity in gene knockout, minimizing off-target effects, which is a common drawback in older methods such as RNA interference. Furthermore, our product is validated through extensive functional assays, ensuring that it meets the rigorous standards demanded by the scientific community.
For researchers and clinicians seeking to unravel the complexities of gene function, the MSANTD7 Gene Knockout Cell Lines provide a cutting-edge solution that drives impactful discoveries. Our company, recognized for its commitment to biological research and innovation, stands ready to support your scientific endeavors with high-quality tools designed to enhance reproducibility and enhance experimental clarity.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.